Changes

Jump to navigation Jump to search
947 bytes added ,  09:41, 20 August 2011
Improved sales data, class action complaint added
Line 1: Line 1:  +
[[image:Sales_Boiron.gif|Consolidated Sales 2008/2010 (Source: <ref name='Report2010'>http://www.boiron.com/en/content/download/3589/22995/file/BOIRON%202010_GB.pdf</ref>)|226px|thumb]]
 
[[image:Boiron.jpg|Certificate for alleged student "Donald Duck" as ''Boiron certified specialist'' (Italian: Paperino = Donald Duck, Source: <ref>http://medbunker.blogspot.com/2011/01/paperino-lomeopata.html</ref>)|360px|thumb]]
 
[[image:Boiron.jpg|Certificate for alleged student "Donald Duck" as ''Boiron certified specialist'' (Italian: Paperino = Donald Duck, Source: <ref>http://medbunker.blogspot.com/2011/01/paperino-lomeopata.html</ref>)|360px|thumb]]
 
French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
 
French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
   −
In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit). In 2004, it employed a workforce of 2,779 persons. The majority of shares is held by the Boiron family, the managing director also is a member of this family .
+
In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit) with a decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in Francce was 279&nbsp;million Euros. In 2010, it employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the managing director also is a member of this family.<ref name='Report2010' />
    
In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.
 
In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.
Line 24: Line 25:     
:''Main results - ... There was no evidence that homoeopathic treatment can prevent influenza-like syndrome...Oscillococcinum treatment reduced the length of influenza illness by 0.28 days (95% CI 0.50 to 0.06). Oscillococcinum also increased the chances that a patient considered treatment to be effective (RR 1.08; 95% CI 1.17 to 1.00)...Authors' conclusions - Though promising, the data were not strong enough to make a general recommendation to use Oscillococcinum for first-line treatment of influenza and influenza-like syndromes. Further research is warranted but the required sample sizes are large. Current evidence does not support a preventative effect of Oscillococcinum-like homeopathic medicines in influenza and influenza-like syndromes.''<ref>Andrew Vickers, Claire Smith: ''Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes'', The Cochrane Library, 15.4.2009, DOI: 10.1002/14651858.CD001957.pub3 [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001957.pub3/abstract abstract]</ref>
 
:''Main results - ... There was no evidence that homoeopathic treatment can prevent influenza-like syndrome...Oscillococcinum treatment reduced the length of influenza illness by 0.28 days (95% CI 0.50 to 0.06). Oscillococcinum also increased the chances that a patient considered treatment to be effective (RR 1.08; 95% CI 1.17 to 1.00)...Authors' conclusions - Though promising, the data were not strong enough to make a general recommendation to use Oscillococcinum for first-line treatment of influenza and influenza-like syndromes. Further research is warranted but the required sample sizes are large. Current evidence does not support a preventative effect of Oscillococcinum-like homeopathic medicines in influenza and influenza-like syndromes.''<ref>Andrew Vickers, Claire Smith: ''Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes'', The Cochrane Library, 15.4.2009, DOI: 10.1002/14651858.CD001957.pub3 [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001957.pub3/abstract abstract]</ref>
 +
 +
In August 2011 a class action complaint was filed in California:
 +
:"Oscillococcinum(the "Oscillo") is nothing more than a sugar pill that Defendants falsely advertise has the ability to cure the flu. In reality, Oscillo has no impact on the flu or any symptoms that accompany the flu."<ref>[http://www.courthousenews.com/2011/08/05/SnakeOil.pdf Boiron Oscillococcinum Class Action Lawsuit], CourtHouseNews</ref>
    
==Lawsuit threats against Boiron-critic and blogger Samuele Riva==
 
==Lawsuit threats against Boiron-critic and blogger Samuele Riva==
Line 43: Line 47:     
According to BMJ, Boiron is "monitoring all media including the web to see what is being said about our company".
 
According to BMJ, Boiron is "monitoring all media including the web to see what is being said about our company".
 
+
 +
http://www.topclassactions.com/lawsuit-settlements/lawsuit-news/1309--boiron-oscillococcinum-class-action-lawsuit
 
{{OtherLang|fr=Boiron|ge=Boiron|en=Boiron}}
 
{{OtherLang|fr=Boiron|ge=Boiron|en=Boiron}}
   Line 58: Line 63:  
*http://www.homeowatch.org/history/oscillo.html
 
*http://www.homeowatch.org/history/oscillo.html
 
*http://www.sciencebasedmedicine.org/index.php/homeopathic-thuggery
 
*http://www.sciencebasedmedicine.org/index.php/homeopathic-thuggery
 +
*http://www.guardian.co.uk/science/blog/2010/feb/04/homeopathic-association-evidence-commons-committee
 
----------------------------------
 
----------------------------------
 
*http://blog.psiram.com/?p=3832
 
*http://blog.psiram.com/?p=3832
reviewer
820

edits

Navigation menu